Veeva Systems Total Non-Cash Items 2012-2025 | VEEV

Veeva Systems annual/quarterly total non-cash items history and growth rate from 2012 to 2025. Total non-cash items can be defined as the total of all non-cash charges adjusting Net Income on the Cash Flows Statement
  • Veeva Systems total non-cash items for the quarter ending January 31, 2025 were $0.368B, a 13.39% increase year-over-year.
  • Veeva Systems total non-cash items for the twelve months ending January 31, 2025 were $0.870B, a 6.57% increase year-over-year.
  • Veeva Systems annual total non-cash items for 2025 were $0.368B, a 13.39% increase from 2024.
  • Veeva Systems annual total non-cash items for 2024 were $0.325B, a 13.8% increase from 2023.
  • Veeva Systems annual total non-cash items for 2023 were $0.285B, a 9.79% decline from 2022.
Veeva Systems Annual Total Non-Cash Items
(Millions of US $)
2025 $368
2024 $325
2023 $285
2022 $316
2021 $247
2020 $154
2019 $98
2018 $88
2017 $70
2016 $29
2015 $16
2014 $8
2013 $2
2012 $2
2011 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $39.499B $2.747B
Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data).
Stock Name Country Market Cap PE Ratio
Hims & Hers Health (HIMS) United States $14.471B 150.35
Tempus AI (TEM) United States $11.278B 0.00
Inspire Medical Systems (INSP) United States $4.503B 70.36
IRhythm Technologies (IRTC) United States $4.501B 0.00
Privia Health (PRVA) United States $3.050B 208.50
Enovis (ENOV) United States $2.060B 11.48
Clover Health Investments (CLOV) United States $1.807B 0.00
Schrodinger (SDGR) United States $1.722B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.310B 23.11
Azenta (AZTA) United States $1.258B 58.45
10x Genomics (TXG) United States $1.156B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.376B 834.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.142B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.089B 3.39
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.068B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.040B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00